Erratum to: Incidence of second hip fracture and compliant use of bisphosphonate (Osteoporosis International DOI: 10.1007/s00198-012-2250-0);Incidence of second hip fracture and compliant use of bisphosphonate

Osteoporosis International

Volumn 24, Issue 7, 2013, Pages 2099-2104

  Lee, Y K ^a   Ha, Y C ^b   Yoon, B H ^a   Koo, K H ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Bisphosphonate; Compliance; Hip fracture; Second hip fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; FEMALE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION;

EID: 84879228998     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2731-4     Document Type: Erratum

References (47)

1. Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285-289
2. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3-S7
3. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA (2005) Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res 20:579-587
4. Koval KJ, Zuckerman JD (1994) Functional recovery after fracture of the hip. J Bone Joint Surg Am 76:751-758
5. Yoon HK, Park C, Jang S, Lee YK, Ha YC (2011) Incidence and mortality following hip fracture in Korea. J Korean Med Sci 26:1087-1092
6. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005
7. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878-882
8. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
9. Melton LJ, 3rd, Ilstrup DM, Beckenbaugh RD, Riggs BL (1982) Hip fracture recurrence. A population-based study. Clin Orthop Relat Res 167:131-138
10. Mouzopoulos GJ, Stamatakos MK, Mouzopoulos DJ (2007) Does penis radiological shadow indicate the side of hip fracture? J Postgrad Med 53:217
11. Finsen V, Benum P (1986) Past fractures indicate increased risk of hip fracture. Acta Orthop Scand 57:337-339
12. Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR (2003) Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures. Osteoporos Int 14:130-136
13. Berry SD, Samelson EJ, Hannan MT, McLean RR, Lu M, Cupples LA, Shaffer ML, Beiser AL, Kelly-Hayes M, Kiel DP (2007) Second hip fracture in older men and women: the Framingham study. Arch Intern Med 167:1971-1976
14. Kim SM, Moon YW, Lim SJ, Yoon BK, Min YK, Lee DY, Park YS (2012) Prediction of survival, second fracture, and functional recovery following the first hip fracture surgery in elderly patients. Bone 50(6):1343-1350
15. Lawrence TM, Wenn R, Boulton CT, Moran CG (2010) Age-specific incidence of first and second fractures of the hip. J Bone Joint Surg Br 92:258-261
16. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. http://www.nof.org/physguide/. Accessed 15 Feb 2006
17. Javid KS, Thien A, Hill R (2008) Implementation of and compliance with NICE guidelines in the secondary prevention of osteoporotic fractures in postmenopausal women. Ann R Coll Surg Engl 90:213-215
18. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM (2010) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract 16(6):1016-1019
19. Follin SL, Black JN, McDermott MT (2003) Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 23:190-198
20. Formiga F, Rivera A, Nolla JM, Coscujuela A, Sole A, Pujol R (2005) Failure to treat osteoporosis and the risk of subsequent fractures in elderly patients with previous hip fracture: a five-year retrospective study. Aging Clin Exp Res 17:96-99
21. Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am 90:2142-2148
22. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767-773
23. Grisso JA, Kelsey JL, Strom BL, O'Brien LA, Maislin G, LaPann K, Samelson L, Hoffman S (1994) Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group. N Engl J Med 330:1555-1559
24. Baron JA, Farahmand BY, Weiderpass E, Michaelsson K, Alberts A, Persson I, Ljunghall S (2001) Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 161:983-988
25. Soong YK, Tsai KS, Huang HY, Yang RS, Chen JF, Wu PC, Huang KE (2012) Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int. doi: 10.1007/s00198-012-1984-z
26. Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F (2007) A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin 23:585-594
27. Owens WD, Felts JA, Spitznagel EL Jr (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49:239-243
28. Koval KJ, Aharonoff GB, Rosenberg AD, Bernstein RL, Zuckerman JD (1998) Functional outcome after hip fracture. Effect of general versus regional anesthesia. Clin Orthop Relat Res 348:37-41
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
30. McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083-2098
31. McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028-1034
32. Navarro RA, Greene DF, Burchette R, Funahashi T, Dell R (2011) Minimizing disparities in osteoporosis care of minorities with an electronic medical record care plan. Clin Orthop Relat Res 469:1931-1935
33. Lih A, Nandapalan H, Kim M, Yap C, Lee P, Ganda K, Seibel MJ (2011) Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int 22:849-858
34. Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88:25-34
35. Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272-282
36. Souder CD, Brennan ML, Brennan KL, Song J, Williams J, Chaput C (2012) The rate of contralateral proximal femoral fracture following closed reduction and percutaneous pinning compared with arthroplasty for the treatment of femoral neck fractures. J Bone Joint Surg Am 94:418-425
37. Kok LM, van der Steenhoven TJ, Nelissen RG (2011) A retrospective analysis of bilateral fractures over sixteen years: localisation and variation in treatment of second hip fractures. Int Orthop 35:1545-1551
38. Cree MW, Juby AG, Carriere KC (2003) Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int 14:722-727
39. Karachalios T, Lyritis GP, Kaloudis J, Roidis N, Katsiri M (2004) The effects of calcitonin on acute bone loss after pertrochanteric fractures. A prospective, randomised trial. J Bone Joint Surg Br 86:350-358
40. Kim SR, Ha YC, Park YG, Lee SR, Koo KH (2011) Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. J Korean Med Sci 26:1501-1507
41. Gong HS, Oh WS, Chung MS, Oh JH, Lee YH, Baek GH (2009) Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am 91:2376-2380
42. Lee YK, Nho JH, Ha YC, Koo KH (2011) Persistence with intravenous zoledronate in elderly patients with osteoporosis. Osteoporos Int 23:2329-2333
43. Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023-1031
44. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, Jonsson B, Pols H, Cramer JA (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 18:711-719
45. Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, Yanagimoto K, Sakota K (2007) Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab 25:302-309
46. Melton LJ III, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20(5):687-694
47. Stewart A, Walker LG, Porter RW, Reid DM, Primrose WR (1999) Predicting a second hip fracture. J Clin Densitom 2:363-370